Last week we participated in a workshop "Human Challenge Trial workshop: Focus on the quality requirements for challenge agents" in (October 22, 2019, Paul-Ehrlich-Institut, Germany).
It was a really interesting meeting where participants including representives from different regulatory agencies in the world discussed about the quality requirement for challenge agents, as no stardardised guidelines currently exist.
See the conclusion of the meeting and the recommendations here on the right hand panel.
- India: Side Meeting on the Current Global Regulatory and Ethical Landscape for CHIM studies [meeting summary]
- Zambia: Development of an Ethical and Regulatory Framework for the Conduct of Controlled Human Infection Studies [Expert Consultation Report]
- Melissa Kapulu: Malaria transmission and human infection studies [Interview@University of Oxford]